Intracellular Delivery of siRNAs Targeting AKT and ERBB2 Genes Enhances Chemosensitization of Breast Cancer Cells in a Culture and Animal Model

siRNAs targeting multidrug transporter genes sensitize breast tumor to doxorubicin in a syngeneic mouse model

(2018) Snigdha Tiash et al.   JOURNAL OF DRUG TARGETING

Knockdown of ROS1 gene sensitizes breast tumor growth to doxorubicin in a syngeneic mouse model

(2016) SNIGDHA TIASH et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy

(2016) Chun-ge Zhang et al.   Scientific Reports

Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation

(2015) Francesca De Iuliis et al.   TUMOR BIOLOGY

Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

(2013) Huan Meng et al.   ACS Nano

Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA

(2013) Oleh Taratula et al.   JOURNAL OF CONTROLLED RELEASE

NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivity

(2012) Sarala Manandhar et al.   FREE RADICAL BIOLOGY AND MEDICINE

Protein-based nanocarriers as promising drug and gene delivery systems

(2012) Ahmed O. Elzoghby et al.   JOURNAL OF CONTROLLED RELEASE

Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer

(2011) Ding-Ding Guo et al.   BIOMATERIALS

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

(2011) Y. Zhao et al.   CANCER RESEARCH

Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide

(2011) Liming Zhang et al.   Small

Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line

(2010) Huan Meng et al.   ACS Nano

Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer

(2010) N Mori et al.   BRITISH JOURNAL OF CANCER

Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA–PCL–PDMAEMA triblock copolymers

(2009) Caihong Zhu et al.   BIOMATERIALS

Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells

(2008) D. L. Shattuck et al.   CANCER RESEARCH

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

(2008) C Garcia-Echeverria et al.   ONCOGENE